Rationale: Primary ciliary dyskinesia (PCD) is an inherited disorder characterized by heterogeneous airway disease. Traditional lung function techniques (e.g., spirometry) may underestimate severity and complexity of PCD.
Primary ciliary dyskinesia (PCD) is an autosomal recessive inherited disorder of considerable clinical and genetic heterogeneity (1) . The main feature of PCD is decreased airway clearance due to impaired ciliary motility (2) . This results in localized airway infections, ventilation defects, and heterogeneous impairments to pulmonary function and structure (1, (3) (4) (5) . A major challenge of the current clinical care in PCD is the ability to detect and monitor subclinical lung disease (5, 6) . Spirometry has been traditionally used to assess airflow limitation (7) (8) (9) , whereas the multiple breath washout (MBW) technique is more sensitive for the detection of subclinical small airway disease (10) . Still, lung function tests alone cannot differentiate between reversible and irreversible structural defects, and may underestimate disease severity.
Lung imaging is thus needed to directly assess the presence and extent of structural lung disease in individuals with PCD. High-resolution computed tomography (HRCT) is considered the gold standard for assessing structural abnormalities in lung disease (7, 11, 12) . However, HRCT scans expose individuals to ionizing radiation, and functional information from HRCT scans is limited (13, 14) . Aside from HRCT, magnetic resonance (MR) imaging (MRI) techniques can provide information on structural and functional deficits in the lung without radiation exposure (15) . Traditionally, functional MRI techniques were constrained by the need for intravenous or inhaled contrast agents (16) (17) (18) (19) (20) . However, the recently developed matrix pencil (MP) decomposition MRI (MP-MRI) method can be used to assess ventilation and perfusion defects in the lung during free tidal breathing and without the need for contrast agents (21) . We have previously shown that the functional MP-MRI method is sensitive for detecting lung ventilation and perfusion impairment in children with cystic fibrosis (CF), and there is a high degree of correlation between lung structure and function outcomes in this population (15) . We hypothesized that functional MP-MRI will also detect impairment of ventilation and perfusion in individuals with PCD. Specifically, we aimed to assess 1) the prevalence and extent of lung function and structure abnormalities, and 2) the concordance and correlation between lung function and structural outcomes in individuals with PCD. Some of the data have been presented previously in abstract form (22) .
Methods

Study Design
This is a prospective cross-sectional, singlecenter, observational study. Recruitment took place between April 2015 and February 2016. Study participants underwent spirometry, nitrogen MBW (N 2 -MBW), structural MRI, and functional MP-MRI on the same day.
Study Population
We enrolled 30 study participants with PCD, aged 5-28 years (median age, 13.4 yr) at the University Children`s Hospital of Ruhr University Bochum, St. Josef Hospital (Bochum, Germany). All study participants had a confirmed diagnosis of PCD according to current guidelines and clinical symptoms coherent to PCD diagnosis (5, 23, 24) (Table 1; see also Table E1 in the online supplement). Eligibility criteria included the absence of acute pulmonary exacerbation during the last 3 weeks before the study (25) .
The study was approved by the Ethics Committee of the Ruhr University Bochum (No. 5,103). We obtained written informed consent from parents and assent from study participants if older than 14 years.
MRI Data Acquisition and Evaluation
All MRI examinations were performed on a 1.5 Tesla whole-body MR-scanner (MAGNETOM Avanto-Fit, Siemens Healthineers) using a 12-channel thorax and a 24-channel spine receiver coil array. Both structural and functional MRIs were obtained during free breathing and without the use of contrast agents within a single MR session. Sedation was not required for MRI assessment, even for the youngest patient (aged 5 yr).
Morphological MRI
The Eichinger MRI morphology score was used to assess the presence and extent of structural lung disease (26) . The structural defects assessed include bronchiectasis/ bronchial wall thickening, mucus plugging, abscess/sacculation, special findings, and consolidation. Individual features are scored Definition of abbreviations: HVM = high-frequency video microscopy; IF = immunofluorescence; IQR = interquartile range; nNO = nasal nitric oxide; PCD = primary ciliary dyskinesia; TEM = transmission electron microscopy. *For further diagnostic details, see Table E1 . Age, height, and weight are given as median and IQR. All other values are given as absolute numbers (n) and, if applicable, as percentage (stated in parenthesis).
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as follows: 0 = not present; 1 = present and affecting 50% or less of the lobe; or 2 = present and affecting greater than 50% of the lobe. The lobe scores for each component were summed to produce a score out of 12.
The total morphology score is composed of five subscores each with a maximum score of 12 (maximum score = 60). The morphological MRI datasets were scored by two board-certified, fellowship-trained radiologists with 9 and 14 years of experience in cross-sectional imaging of the chest. Further details are provided in the online supplement (Table E2 ).
Functional MRI
Functional MRI imaging was performed using the recently developed MP-MRI method, which is a derivative of the Fourier decomposition MRI technique (27) (28) (29) (30) . Functional MRI imaging was performed using time-resolved acquisitions with an ultra-fast, steady-state free precession pulse sequence during relaxed breathing. The MP decomposition method was applied to generate maps of regional fractional ventilation, which reflects changes of lung parenchyma density during respiration, and regional perfusion maps, which reflects changes in blood flow in the lung (21, 30) . The distribution of ventilation and perfusion was assessed, and a threshold was applied to determine the degree of impairment (15, 29) . The relative fractional ventilation (R FV ) and relative perfusion (R Q ) impairment were calculated and expressed as a percentage of lung volume for each study participant. To estimate the degree of functional abnormalities in patients with PCD we relied on historical normal values for MRI (15) . Further details are provided in the online supplement.
Lung Function Assessment
Spirometry. Spirometry was performed using Jaeger MasterScreen body plethysmograph equipment (CareFusion) according to current guidelines (8) . We assessed the forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC) and calculated z-scores from recommended reference equations for spirometry (31) .
MBW. The N 2 -MBW technique was performed using a commercially available device (Exhalyzer D, Eco Medics AG) (32) and in accordance with current consensus guidelines (33, 34) . The primary outcome was the lung clearance index ORIGINAL RESEARCH (LCI). Secondary outcomes included ventilation heterogeneity in the convection dependent airways (S cond ) and ventilation heterogeneity in diffusion-convectiondependent airways (S acin ), which reflect convection and diffusion-convectiondependent ventilation inhomogeneity, respectively. We calculated z-scores for the N 2 -MBW based on published reference values (9) .
Statistical Analysis
Visual inspection of the distribution of our data indicated significant skewing; therefore, the data were expressed as medians and interquartile ranges (IQRs 
Results
All 30 subjects with PCD were able to perform spirometry, N 2 -MBW, and MRI on the same day. The clinical characteristics of the study participants are presented in Table 1 and Table E1 .
Data Quality
After quality control, all 30 study participants had morphological MRI, N 2 -MBW and spirometry data, and 27 study Table E4 are marked as P1-P4. LLN = lower limit of normality; P1-P4 = study participants from Figure 2 and Table E4 ; ULN = upper limit of normality.
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participants had functional MRI data, included in the final analysis. Further details are provided in the online supplement.
MRI
Structural lung abnormalities were present in all study participants. The proportion of study participants with bronchiectasis/ bronchial wall thickening was 97% and mucus plugging was 60% ( Table 2 ). The total morphology score ranged from 3 to 28, and the median (IQR) score for the population was 10.3 (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . The bronchiectasis/bronchial wall thickening scores ranged from 1.5 to 10.5 and the median (IQR) score was 6 (4.5-8). The mucus plugging score ranged from 0.5 to 8.5 and the median (IQR) score was 2.3 (1-4). We found a predominance of defects in the middle and lower lobes (Table E3 ). The agreement between structural MRI readers was good, with an ICC of 0.67 for the total morphology score (Table E2 ).
The proportion of study participants with functional MRI ventilation impairment was 52% and perfusion impairment was 78%. The relative proportion of the lung with impaired R FV (median [IQR]) was 24.2% (21.1-25.2), and R Q was 21.1% (19.4-25.9) ( Table 2) .
Lung Function
The ability to capture abnormal lung function strongly varied between techniques. The proportion of subjects with abnormal values was 27% for FEV 1 , 83% for LCI, 63% for S cond , and 50% for S acin . The median (IQR) of FEV 1 z-score was 20.5 (21.6 to 0.3), LCI was 8.3 (2.6-13.2) z-score, S cond 2.8 (0.9-4.4) z-score, and S acin 1.7 (0.4-6.7) z-score (Table 3) .
Concordance between Lung Function and MRI on the Group and Individual Levels
More than half of the patients (52%) had structural lung disease, functional MRI impairment, and abnormal LCI values, but FEV 1 values within the normal range ( Figure 1 ). Only 15% of subjects had concordant abnormalities in all primary outcome measures. In terms of concordance between two primary outcomes, LCI and total morphology score were concordantly abnormal in 25/30 (83%) subjects, mucus plugging and LCI were concordantly abnormal in 15/30 (50%) subjects, and LCI 
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and R Q were concordantly abnormal in 19/27 (70%) subjects.
To illustrate the complexity of PCD lung disease, MRI and lung function from four individual study participants are presented in Table E4 . Subjects 1 and 2 had FEV 1 values within the normal limits, whereas subjects 3 and 4 had abnormal FEV 1 . In contrast, subjects 1 and 4 had normal LCI values, whereas subjects 2 and 3 had pathological LCI values, which LCI values differed in severity of 7.3 and 24.0 z-scores, respectively. Morphological MRI scores also differed between these subjects. Patient 2 was a 28 year-old female (morphology score = 5) who had rarefaction of the lung parenchyma in the upper lobes, resembling emphysematous changes (a finding that is not captured by score). Patient 3 showed more extensive bronchiectasis/bronchial wall thickening without atelectasis (score = 26). Both these subjects had poorly perfused and ventilated lung regions, although functional impairment on MRI was more pronounced in patient 3. The results from these study participants are outlined in Table E4 and Figures 1 and 2 .
Correlation between Structure and Function Outcomes
Lung function and functional MRI outcomes cannot distinguish between reversible (mucus plugging) and partly irreversible (bronchiectasis/bronchial wall thickening) structural changes (Figure 3, Figures E1 and  E2 ). There were no statistically significant correlations between functional MRI and lung function outcomes (Figure 4 and Table E5 ). However, we found statistically significant, moderate correlations between the total morphology scores and LCI (r = 0.54, P = 0.002) and FEV 1 (r = 20.59, P , 0.001) (Table E5, Figure E3 ).
Discussion
We used comprehensive imaging and function methods to assess lung disease in individuals with PCD. PCD lung disease is characterized by highly prevalent structural pathology with heterogeneous functional consequences. Structural lung disease, functional MRI impairment, and abnormal LCI were present in the majority of patients. FEV 1 , however, was not sensitive enough to detect structural airway disease in this population. Our findings highlight the heterogeneous nature of PCD lung disease and the need for a multimodality approach to characterize and potentially monitor patients with PCD.
Comparison with Previous Literature
We assessed structural lung abnormalities in patients with PCD using morphological MRI. Previous studies have only used HRCT imaging to characterize structural lung disease in patients with PCD (7, 11) . However, studies have shown that MRI can reliably assess structural lung disease in patients with CF lung disease (18, 38) , and demonstrated good agreement between HRCT and MRI in patients with PCD (39). We found that the prevalence and extent of structural lung abnormalities in patients with PCD were similar to what we reported in patients with CF (15) . Therefore, our results indicate that morphological MRI scans can provide a radiation-free method to assess structural lung disease in individuals with PCD.
We found that the correlation between lung structure and function outcomes was weaker in patients with PCD compared with those we reported in patients with CF. Structural lung abnormalities (e.g., ORIGINAL RESEARCH bronchiectasis/bronchial wall thickening) were present in 97% of all subjects, whereas 78% of subjects had abnormal LCI, and only 27% had abnormal FEV 1 . Previous studies using HRCT have reported a strong correlation between LCI and CT morphology scores (r = 0.8) (7), whereas another reported no correlation (11) . The conflicting nature of these data also suggests a multimodality approach to fully and reliably characterize PCD lung disease.
The major advantage of the functional MRI technique used in our study is that it provides data on ventilation and perfusion impairment in the lung without the need for contrast agents or breath-hold maneuvers (18, 20) . This is the first time this technique has been used to assess functional lung impairment in patients with PCD. In contrast to patients with CF, we did not find a correlation between perfusion and ventilation indices from the functional MRI and lung function outcomes in patients with PCD (15) . A previous study used hyperpolarized gas MRI to assess lung ventilation defects in patients with PCD, and reported good correlations between imaging and lung function outcomes (LCI and FEV 1 / FVC) (20) . Lung impairment in patients with PCD is frequently focal in nature with lobar or segmental atelectasis. Focal pathology is difficult to capture by lung function techniques that assess global airflow or ventilation impairment. We determined in our analysis that the middle and lower lobes were more severely (score = 2) and more predominantly affected than the upper lobe. This is in line with previously studies, which showed typical imaging features in PCD, including a predominance of bronchiectasis in the middle and lower lobes (40, 41) , presumably due to greater difficulty in the drainage of secretions. Therefore, relationships between lung imaging and function outcomes can be influenced by the heterogeneity of the disease in individuals with PCD (42) . Further work to define morphological and functional scoring systems specific for the focal nature of lung disease in individuals with PCD is needed.
Clinical Relevance
We recruited individuals with PCD diagnosed based on current European consensus recommendations (5, 23, 24) . Our patient population included a wide age range, with a variety of disease severities, and therefore represents a typical PCD population in tertiary care centers. We provide further evidence that FEV 1 is not sensitive enough to monitor structural airway pathologies in patients with PCD. The LCI from the MBW technique appears to be more sensitive for monitoring early structural lung disease; however, LCI values were not able to distinguish between individuals with reversible and partly irreversible structural disease. Therefore, in patients with normal lung function, lung imaging may be needed to detect early and focal structural changes. Structural and functional MRIs are sensitive tools for monitoring lung disease progression and responses to treatment without the need for radiation exposure or the risks associated with intravenous contrast agents.
Strengths and Limitations
All study participants enrolled in our study were able to perform MRI scans and lung function tests within a 1-day clinic visit. All MRIs were obtained without sedation, contrast agent, or breathing maneuvers, which can be difficult in younger or uncooperative subjects. We included 30 study participants with clear and fulfilled PCD diagnostic criteria. The sample size is comparable to previous studies, and is sufficient to allow meaningful interpretation of the data (7, 11, 15) . The patients with PCD in our study were younger (mean, 13.4 [range, 10.4-17.1]), than the patients in the study of ] yr) and Irving (mean age, 24.7 yr), and therefore have a milder lung disease compared with the older patients in these studies (7, 11) . We did not include retrospective chest CT scans, as these data were not available within a reasonable time before the MRI scans to allow meaningful comparison. We used an established MRI CF score to evaluate structural disease in study participants with PCD (26) . The ICC between scorers was good in our study. However, PCDspecific CT and MRI morphology scoring systems are currently not available. Peripheral bronchiectasis without bronchial wall thickening, and discrete mucus plugging of small airways cannot be well visualized by MRI (14) . In addition, hyperinflation of the lung may be underestimated using a CF scoring system. We did not recruit prospective healthy controls in this study, but relied on previously published normative data from our group using the same equipment for both MRI and lung function outcomes (15) . Furthermore, the automatic functional lung evaluation method, as used in this work, relies on segmentation of the whole-lung volume to calculate global ventilation or perfusion impairment. Currently, no lobar segmentation method is available, as it poses a significant challenge in comparison to well-established lobar segmentation methods known from CT.
Outlook
Sensitive and feasible techniques for functional lung MRI in children are now available. We encourage the use of MRI for future investigative studies in patients with PCD to allow for better understanding of this complex lung disease. Future interventional trials should consider the use of a combination of novel MRI techniques and lung function outcomes to collectively monitor responses to treatments in PCD lung disease.
Conclusions
In summary, we assessed airflow limitation, ventilation, perfusion, and structural airway impairment in patients with PCD using novel MRI sequences without the need for contrast agents or breathing maneuvers. The poor correlation between spirometry and imaging outcomes in our study supports the use of both MRI and sensitive lung function techniques to assess lung disease in individuals with PCD. Although LCI was more sensitive for the detection of lung disease than FEV 1 , LCI was not able to discriminate between reversible and irreversible airway disease in our study. Longitudinal studies using a combination of MRI and LCI may help us to understand the complex relationships between PCD genotypes, ciliary function phenotypes, lung morphology, and functional impairment. n Author disclosures are available with the text of this article at www.atsjournals.org.
